Gil Blum, an analyst from Needham, reiterated the Buy rating on Sarepta Therapeutics (SRPT – Research Report). The associated price target was ...
Massachusetts Financial Services Co. MA reduced its stake in Ecolab Inc. (NYSE:ECL – Free Report) by 1.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the ...
Massachusetts Financial Services Co. MA raised its position in Tronox Holdings plc (NYSE:TROX – Free Report) by 18.0% during ...